Thrive Capital Management (Pennsylvania)’s Merit Medical Systems MMSI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.81M Buy
69,350
+21,120
+44% +$1.39M 0.91% 36
2026
Q1
$3.32M Buy
48,230
+7,333
+18% +$573K 0.73% 68
2025
Q4
$3.6M Buy
40,897
+15,095
+59% +$1.28M 0.8% 59
2025
Q3
$2.15M Buy
25,802
+5,944
+30% +$518K 0.55% 79
2025
Q2
$1.86M Buy
19,858
+14,132
+247% +$1.34M 0.58% 78
2025
Q1
$605K Sell
5,726
-8,471
-60% -$874K 0.36% 61
2024
Q4
$1.37M Buy
14,197
+7,875
+125% +$785K 0.63% 75
2024
Q3
$625K Sell
6,322
-863
-12% -$79K 0.29% 95
2024
Q2
$618K Buy
7,185
+4,092
+132% +$322K 0.28% 99
2024
Q1
$234K Buy
+3,093
New +$239K 0.12% 107

Other funds holding MMSI

Thrive Capital Management (Pennsylvania)'s MMSI Position: Q2 2026 in Review

Thrive Capital Management (Pennsylvania) increased its Merit Medical Systems (MMSI) stake by 44% in Q2 2026, buying an estimated $1.39M and bringing the position to 69,350 shares worth $4.81M. The position accounts for 0.91% of the portfolio, ranked #36.

Thrive Capital Management (Pennsylvania) first reported a position in MMSI in Q1 2024 and has held it in 10 quarters since. 403 funds tracked by Wall St. Rank hold MMSI as of Q2 2026.

  • Thrive Capital Management (Pennsylvania) held 69,350 shares of Merit Medical Systems worth $4.81M as of Q2 2026.
  • Thrive Capital Management (Pennsylvania) bought 21,120 Merit Medical Systems shares in Q2 2026, an estimated $1.39M.
  • Merit Medical Systems made up 0.91% of Thrive Capital Management (Pennsylvania)'s portfolio in Q2 2026, its #36 holding.
  • Thrive Capital Management (Pennsylvania) first reported a position in Merit Medical Systems in Q1 2024 and has held it in 10 quarters since.
  • 403 funds tracked by Wall St. Rank held Merit Medical Systems as of Q2 2026.

Based on Thrive Capital Management (Pennsylvania)'s 13F filing for Q2 2026, filed 5 Aug 2026.